Notably, a high expression level of EphA2 protein was significantly associated with the RCC TNM classification (P=0.001), the size of tumor (P=0.001) and the presence of lymph node metastasis (P=0.022), respectively. This evidence concerns the gene EPHA2 and metastatic malignant neoplasm in the lymph nodes.